Making synthetic
skin to heal wounds?Making synthetic
skin to heal wounds?There's an ASX
stock for that.
Popular ASX biotechnology stocks on Stake
| Ticker | Company Name | Price | Market Cap | |
|---|---|---|---|---|
CSL | CSL Limited | $301.70 | $143.35B | Trade now |
NEU | Neuren Pharmaceuticals Limited | $23.62 | $3.05B | Trade now |
IMU | Imugene Limited | $0.10 | $753M | Trade now |
TLX | Telix Pharmaceuticals Limited | $11.50 | $3.77B | Trade now |
DXB | Dimerix Limited | $0.21 | $95M | Trade now |
Data as of 31 January 2024 for share price and market cap. The information displayed in the table is based on trade volume on Stake's trading platform for the period (1 January 2024 - 31 January 2024) and should not be relied on to make investment decisions. This is for information purposes only and is not a recommendation to invest in the securities listed. It does not constitute financial product advice. We recommend that you do your own research and consider your own personal financial needs, objectives and circumstances before making any investment decision. Stake does not accept any responsibility for any decisions made based on the data provided.
What's happening in the biotechnology sector
Why build your wealth with Stake?
Borderless investing
From CHESS-sponsored ASX trades to fractional shares on Wall St
Aussie-owned
Founded, operated and headquartered in Sydney, Australia
Outstanding value
$3 brokerage on all trades up to $30k
Intuitive experience
Powerful yet easy-to-use experience on mobile and desktop
Start with $10 on us
Get $10 trading credit when you sign up & fund Stake AUS.
Plus, unlock a full U.S. stock when you fund Stake Wall St.